World Journal of Pharmacology and Toxicology
Open Access

Immunotoxicity refers to the harmful effects that chemicals, drugs, or environmental factors can have on the immune system, leading to altered immune responses, increased susceptibility to infections, or autoimmune disorders. The immune system plays a crucial role in defending the body against pathogens, foreign substances, and abnormal cells. When disrupted by immunotoxic agents, the body’s ability to effectively recognize and respond to these threats can be compromised. Chemicals such as pesticides, industrial pollutants, and even certain pharmaceuticals can have immunotoxic effects, either by directly damaging immune cells or by interfering with the normal functioning of immune pathways [1]. Immunotoxicity can manifest in a variety of ways, including immunosuppression, hypersensitivity reactions, or the development of autoimmune conditions. Understanding immunotoxicity is critical for assessing the safety of drugs and chemicals, particularly in the context of regulatory evaluations, and for developing therapeutic strategies to mitigate these adverse effects. This article explores the mechanisms, causes, and consequences of immunotoxicity, as well as the methods used to evaluate its impact on human health.

Discussion
Mechanisms of Immunotoxicity

Immune cell alteration or destruction: Many chemicals and drugs can directly affect immune cells, such as T-cells, B-cells, macrophages, and dendritic cells. For example, certain chemotherapy agents, immunosuppressive drugs, and environmental pollutants may damage or deplete these cells, leading to impaired immune function. T-cell depletion, for example, can lead to reduced cellular immunity, making the body more susceptible to infections. Disruption of cytokine production Cytokines are signaling molecules that regulate immune responses. Immunotoxic agents can interfere with the production or function of cytokines, leading to either excessive immune activation or suppression [2]. For instance, some chemicals may reduce the levels of pro-inflammatory cytokines needed for proper immune activation, resulting in weakened defense mechanisms.

Modulation of immune tolerance: The immune system has mechanisms that distinguish between harmful invaders and the body’s own cells. Immunotoxic substances may disrupt immune tolerance, leading to the development of autoimmune diseases. For example, some chemicals can alter the signaling pathways that prevent the immune system from attacking the body’s tissues, increasing the risk of autoimmune conditions like lupus or rheumatoid arthritis [3].

Oxidative stress and inflammation: Many immunotoxicants induce oxidative stress, which leads to the production of free radicals that can damage immune cells and tissues. Oxidative stress may activate inflammatory pathways that disrupt the normal functioning of immune responses, contributing to chronic inflammation and immune system dysregulation.

Types of Immunotoxicity

Immunosuppression: Exposure to immunotoxic agents can suppress the immune system’s ability to mount an effective defense against infections. This can lead to an increased susceptibility to bacterial, viral, and fungal infections. Immunosuppressive effects are often seen in individuals who receive immunosuppressive drugs, such as those undergoing organ transplantation or receiving chemotherapy [4]. Long-term exposure to environmental pollutants like pesticides or heavy metals can also suppress immune function.

Hypersensitivity reactions: Some substances can trigger allergic reactions or hypersensitivity responses by stimulating the immune system inappropriately. Common examples of immunotoxic agents that can cause hypersensitivity reactions include certain drugs (e.g., penicillin), metals (e.g., nickel), and environmental allergens. These reactions can manifest as skin rashes, respiratory issues, or systemic reactions like anaphylaxis.

Autoimmunity: Chemicals and drugs can interfere with immune tolerance, leading to autoimmune diseases in which the body’s immune system mistakenly attacks its own cells and tissues. Immunotoxic substances can induce changes in self-antigens, leading the immune system to recognize the body’s own tissues as foreign [5,6]. Examples of drugs linked to autoimmune diseases include hydralazine (a treatment for high blood pressure) and procainamide (used for arrhythmias), which can cause drug-induced lupus.

Environmental and Occupational Exposure to Immunotoxic Agents:

Immunotoxicity is not only a concern with pharmaceuticals but also with various environmental and occupational chemicals. Workers in industries such as agriculture, construction, and manufacturing may be exposed to toxic substances that affect immune health. Pesticides, herbicides, and industrial chemicals like benzene and polycyclic aromatic hydrocarbons (PAHs) are known to have immunotoxic effects, potentially increasing the risk of infections and autoimmune disorders in exposed individuals. Similarly, environmental pollutants such as air pollution (containing particulate matter and heavy metals) and cigarette smoke have been shown to compromise immune function [7]. Chronic exposure to these pollutants can weaken the immune system, making individuals more vulnerable to respiratory infections, allergies, and even cancer.

Drug-Induced Immunotoxicity

Certain pharmaceutical drugs, particularly those with immunosuppressive or cytotoxic properties, can cause immunotoxic effects as unintended side effects. Chemotherapy drugs, for instance, are designed to target and kill rapidly dividing cancer cells but can also affect normal immune cells, leading to immune suppression. Other drugs like corticosteroids, used to treat inflammation and autoimmune disorders, can suppress the immune system over time, increasing the risk of infections and complicating disease management. Biologics, such as monoclonal antibodies and immune checkpoint inhibitors, have revolutionized cancer treatment by stimulating the immune system to attack cancer cells [8]. However, they may also induce immune-related adverse effects, such as immune-mediated inflammation and autoimmunity. These drugs highlight the delicate balance between stimulating and suppressing immune responses.

Assessing Immunotoxicity

Accurately assessing immunotoxicity is essential for understanding the safety of chemicals and drugs, especially in the context of regulatory evaluations. Several approaches are used to detect and characterize immunotoxic effects:
In Vivo Models: Animal studies are commonly used to evaluate the impact of chemicals and drugs on immune function. These models can provide insight into how substances affect immune cell populations, cytokine production, and the ability to fight infections. Rodent models are particularly valuable for studying immunosuppressive and hypersensitivity reactions [9]. In vitro assays using cultured immune cells allow for a controlled environment to study specific immune responses, such as cell proliferation, cytokine release, and immune cell function. These tests can help identify potential immunotoxic agents early in the drug development process.

Biomarkers of immunotoxicity: Certain biomarkers, such as changes in white blood cell counts, cytokine levels, or autoantibodies, can indicate immune system dysfunction. Monitoring these biomarkers can provide early warning signs of immunotoxicity and help guide treatment decisions.

Mitigating Immunotoxicity

Efforts to minimize immunotoxicity include designing drugs with more selective mechanisms of action, improving drug formulations to reduce off-target effects, and using pharmacogenomic strategies to tailor treatments based on individual immune responses. For chemicals and environmental agents, regulatory measures to limit exposure, such as stricter guidelines for pesticide use or industrial emissions, are essential in protecting public health. In clinical settings, managing drug-induced immunotoxicity may involve dose adjustments, switching medications, or employing therapies to support immune recovery [10]. For example, immunosuppressive drugs like corticosteroids can be tapered to reduce their impact on immune function, while vaccines and prophylactic treatments can help prevent infections in immunocompromised patients.

Conclusion

Immunotoxicity is a critical concern in both environmental and clinical settings, as exposure to certain chemicals and drugs can significantly impair the immune system. Whether causing immune suppression, hypersensitivity reactions, or autoimmune disorders, immunotoxic agents can compromise the body’s ability to defend against infections and maintain overall immune balance. Understanding the mechanisms behind immunotoxicity is essential for identifying at-risk populations, developing safer drugs, and mitigating the impact of environmental and occupational exposures. Advances in assessing immunotoxicity through in vitro models, biomarkers, and animal studies have improved our ability to detect and understand these harmful effects. Furthermore, through careful drug design, regulatory measures, and individualized treatment approaches, the risks associated with immunotoxicity can be minimized, ensuring that the benefits of therapeutic drugs outweigh potential harms. Ultimately, a deeper understanding of immunotoxicity is essential for safeguarding public health and optimizing the safety of chemicals and pharmaceuticals in clinical practice.

Acknowledgement

None

Conflict of Interest

None

1. Mockute R, Desai S, Perera S, Assuncao B, Danysz K (2019) Artificial Intelligence within pharmacovigilance: A means to identify cognitive services and the framework for their validation. Pharmaceut Med 33: 109-120.

Indexed at, Google Scholar, Crossref

2. Iwata H, Kojima R, Okuno Y (2021) AIM in pharmacology and drug discovery. Springer.

Google Scholar, Crossref

3. Altman RB (2017) Artificial intelligence (AI) systems for interpreting complex medical datasets. Clin Pharmacol Ther 101: 585-586.

Indexed at, Google Scholar, Crossref

4. Kompa B, Hakim JB, Palepu A, Kompa KG, Smith M (2022) Artificial Intelligence based on machine learning in pharmacovigilance: A scoping review. Drug Saf 45: 477-491.

Indexed at, Google Scholar, Crossref

5. Wen M, Zhang Z, Niu S, Sha H, Yang R, et al. (2017) Deep-learning-based drug-target interaction prediction. J Proteome Res 16: 1401-1409.

Indexed at, Google Scholar, Crossref

6. Minko T, Rodriguez LR, Pozharov V (2013) Nanotechnology approaches for personalized treatment of multidrug resistant cancers. Adv Drug Deliv Rev 65: 1880-1895.

Indexed at, Google Scholar, Crossref

7. Sun M, Zhao S, Gilvary C, Elemento O, Zhou J, et al. (2019) Graph convolutional networks for computational drug development and discovery. Brief Bioinform 21: 919-935.

Indexed at, Google Scholar, Crossref

8. Liang G, Fan W, Luo H, Zhua X (2020) The emerging roles of artificial intelligence in cancer drug development and precision therapy. Biomed Pharmacother 128: 110-225.

Indexed at, Google Scholar, Crossref

9. Murali K, Kaur S, Prakash A, Medhi B (2019) Artificial intelligence in pharmacovigilance: practical utility. Indian J Pharmacol 51: 373-376.

Indexed at, Google Scholar, Crossref

10. Das S, Dey A, Pal A, Roy N (2015) Applications of artificial intelligence in machine learning: review and prospect. Int J Comput Appl 115: 1-9.

Google Scholar, Crossref